🇺🇸 FDA
Pipeline program

Ketamine

30612-01

Phase 3 small_molecule completed

Quick answer

Ketamine for Chronic Pain is a Phase 3 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Chronic Pain
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials